Conference abstract · 24 Jul 2017
Conference abstractPublished 17 Aug 2015
Nanoparticle constructs to overcome the barriers in lung cancer
Florida A&M University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lung cancer is the leading cause of deaths in the United States than any other disease. Non-small cell lung cancer (NSCLC) accounts for 85 percent of all lung cancers. Poor survival rates in NSCLC patients are due to limited efficiency of systemic or oral chemotherapy. Vascular endothelial growth factor (VEGF) over-expression is associated with poor survival. Recently, new approaches in the treatment of lung cancer with novel drugs that selectively inhibit tumor blood supply thus controlling cancer cell survival, proliferation and/or metastasis in combination with conventional anticancer or antiangiogenic drugs have generated clinical interest. DIM-C-pPhC6H5 (DIM-P), a c-substituted diindolylmethanes is novel anti-cancer agent. One of the objectives in my laboratory is to formulate tumor homing pegylated CREKA peptide coated nanolipid carriers of DIM-P and investigate its antitumor activity and antiangiogenic potential for treatment of lung cancer. Further, another objective in my laboratory is to overcome the stromal barriers for tumor penetration by using antifibrotic agents like Telmisartan in combination with nanoparticles. Our results have shown that agents like Telmisartan and Losartan play a significant role in enhancing tumor penetration by reducing collagen levels in tumors and also by inducing apoptosis.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2017
Role of Ultrafine Nanoparticles in Lung Cancer
Conference abstract · 29 May 2017
Targeted nanoparticles was involved in overcoming MDR induced by heterogenous cancer cells
Conference abstract · 28 Nov 2016
Immunotherapy with novel tri-functional lipid nanoparticles to overcome resistance to HER2 therapy in breast cancer
Conference abstract · 12 Jun 2020
Computational modeling of photothermal therapy using gold nanoparticle for Lung cancer treatment
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNanotechnology
- SubjectOncology & Cancer
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Mandip Singh”
